NEA Management Company, LLC - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 53 filers reported holding MERSANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
NEA Management Company, LLC ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$110,966,000
-40.4%
5,959,520
-25.1%
4.70%
-37.3%
Q2 2020$186,253,000
+167.0%
7,959,520
-33.5%
7.49%
+105.5%
Q1 2020$69,748,000
+1.7%
11,963,6490.0%3.64%
+12.4%
Q4 2019$68,552,000
+262.7%
11,963,6490.0%3.24%
+107.2%
Q3 2019$18,903,000
-60.8%
11,963,649
+0.6%
1.56%
-53.6%
Q2 2019$48,172,000
-23.0%
11,894,2670.0%3.38%
+3.9%
Q1 2019$62,564,000
+88.3%
11,894,267
+46.0%
3.25%
+146.4%
Q4 2018$33,229,000
-59.2%
8,144,2670.0%1.32%
-62.5%
Q3 2018$81,443,000
-44.0%
8,144,2670.0%3.51%
-48.4%
Q2 2018$145,457,000
+13.3%
8,144,2670.0%6.81%
+19.3%
Q1 2018$128,435,000
-4.0%
8,144,2670.0%5.71%
+3.1%
Q4 2017$133,810,000
-5.0%
8,144,2670.0%5.54%
+12.4%
Q3 2017$140,814,000
+23.8%
8,144,2670.0%4.93%
+19.1%
Q2 2017$113,775,0008,144,2674.14%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders